JUL 11, 2014 12:00 AM PDT

Weight Loss Is Critical in Reducing Cardiovascular Risk for Patients with Obstructive Sleep Apnea

WRITTEN BY: Ilene Schneider
Obesity and obstructive sleep apnea (OSA) can increase cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients. New research from a multidisciplinary team at the Perelman School of Medicine at the University of Pennsylvania now reveals that the single most important factor for improving cardiovascular health in obese OSA patients is weight loss. The study results are published in the New England Journal of Medicine.

"In the U.S. almost 1 in 5 adults has sleep apnea, which is associated with an increased risk for a variety of cardiovascular complications. Sleep apnea and obesity are strongly associated with each other. We performed this study to find out to what degree obesity and OSA contribute to the burden of cardiovascular risk factors and to quantify the reduction in these risk factors achieved by weight loss, therapy for sleep apnea, or the combination of both" said lead study author Julio Chirinos, MD,PhD, assistant professor of Medicine at Penn.

In the trial, the investigators randomly assigned 181 participants with obesity, moderate-to-severe obstructive sleep apnea and high C-reactive protein levels (CRP) -- an inflammatory marker associated with heart disease -- for 24 weeks to either weight loss therapy, CPAP therapy or the combination of weight loss and CPAP. The authors then evaluated the incremental effect of combination therapy with CPAP and weight loss over each therapy alone, on subclinical inflammation, insulin resistance, dyslipidemia and blood pressure in obese subjects with OSA.

The investigators found no significant effect of combination therapy over either therapy alone when it came to reducing CRP levels. Weight loss alone significantly reduced CRP, insulin resistance, dyslipidemia and high blood pressure. In stark contrast, they did not observe a significant effect of CPAP on CRP, insulin sensitivity or dyslipidemia, even among subjects who adhered to therapy. "These data argue against an independent causal relationship between obstructive sleep apnea and these cardiovascular risk factors in this population and suggest that CPAP is not an effective therapy to reduce the burden of these particular risk factors. These findings also indicate that weight loss therapy should be a central component of strategies to improve the cardiovascular risk factor profile of obese patients with OSA," said Chirinos.

Despite the lack of an effect of CPAP therapy on the risk factors mentioned above, both CPAP and weight loss reduced blood pressure. Furthermore, among subjects who adhered to therapy, CPAP provided an incremental effect over weight loss-only (i.e., participants randomized to combination therapy had a more pronounced effect on blood pressure than participants receiving either therapy alone). "The design of this trial allowed us to conclude that both obesity and sleep apnea are causally related to high blood pressure," Chirinos added.

In addition, the results suggest that adhering to a regimen of weight loss and CPAP therapy will result in larger reductions in blood pressure as compared with either therapy alone.

The study opens several questions for future research. "Effective weight reduction interventions as applied in our study are costly and require a multidisciplinary team with expertise in weight loss. Future research should assess how to best deliver effective weight loss programs for these patients. In addition, more research on strategies to enhance CPAP adherence or to identify subjects that are most likely to demonstrate an important reduction in blood pressure with CPAP would be desirable," said Chirinos.

Other study authors from Penn include Indira Gurubhagavatula, MD, Daniel J. Rader, MD, Thomas Wadden, PhD, Raymond Townsend, MD, Greg Maislin, MS, Hassam Saif, MD, Jesse Chittam, MS, Preston Broderick, Alexandra L. Hanlon, PhD and Allan Pack, MD. The study was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (R01080076 and P01 HL094307).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 25, 2019
Cardiology
JUL 25, 2019
Strict Plant Based Diet Benefits Heart Health
Plant-based diets are steadily gaining popularity with the general public. As a wave of interest fuels research into the health benefits of such diets, stu...
JUL 24, 2019
Cardiology
JUL 24, 2019
Eel Inspired Battery May Someday Power Pacemakers
The worlds first synthetic battery called a “voltaic stack” was developed by Alessandro Volta, an Italian scientist in 1799. The incredible bod...
AUG 08, 2019
Cardiology
AUG 08, 2019
The Best Way to Test Blood Pressure and Find Heart Disease
Heart disease causes hundreds of thousands of deaths annually -- can a new study on blood pressure tests guide doctors toward earlier diagnosis? About one ...
SEP 16, 2019
Drug Discovery & Development
SEP 16, 2019
Injectable Hydrogel Found Safe for Heart Repair
The first successful in-human clinical trial of an injectable hydrogel that aims to repair heart damage and restore cardiac function was recently conducted...
OCT 28, 2019
Health & Medicine
OCT 28, 2019
An Avocado a Day for Heart Health
There’s more great news for avocado lovers! The beloved tree fruit has undoubtedly skyrocketed in popularity over the last few decades thanks to a mu...
NOV 20, 2019
Cardiology
NOV 20, 2019
Americans Continue to Gain Weight Despite Increased Weight loss Efforts
Body mass index (BMI) is an important health measure. BMI is defined by the Centers for Disease Control and Prevention (CDC) as “a person's weigh...
Loading Comments...